Table 6 Previous studies for clinical features of patients with ONFH
Authors | Year | No. of patients with AVN | Study design | FICAT stage | Corticosteroid | THA | Conclusion |
|---|---|---|---|---|---|---|---|
Tsai et al | 2020 | 39 | Retrospective | III & IV | 95.5% | – | High daily doses of prednisolone were associated with a significant risk of AVN |
Shigemura et al | 2011 | 337 | Prospective | – | 51.3% | – | The incidence of corticosteroid-related to osteonecrosis varies among different underlying diseases |
Maniwa et al | 2000 | 19 | Cross-sectional | I, II | 66.7% | 30.8% | Core decompression provides an effective treatment for steroid-associated osteonecrosis other than in cases with SLE |
Mont et al | 1997 | 50 | Cross-sectional | II, III, IV | 61.1% | 68% | None of the factors that have been found to be related to AVN in SLE patients could be related to disease progression |